Pangestu Stevanus, Purba Fredrick Dermawan, Setyowibowo Hari, Azhar Yohana, Mukuria Clara, Rencz Fanni
Department of Health Policy, Corvinus University of Budapest, Budapest, Hungary; Doctoral School of Business and Management, Corvinus University of Budapest, Budapest, Hungary; Faculty of Economics and Business, Atma Jaya Catholic University of Indonesia, Jakarta, Indonesia.
Department of Psychology, Faculty of Psychology, Universitas Padjadjaran, Bandung, Indonesia.
Value Health. 2025 Mar;28(3):449-459. doi: 10.1016/j.jval.2024.12.003. Epub 2024 Dec 27.
The EQ Health and Wellbeing (EQ-HWB) is a new generic measure that captures constructs beyond health-related quality of life, with a 25-item long form and a shorter 9-item version (EQ-HWB-S). This study aimed to assess the psychometric performance of both versions in breast cancer, which is the most prevalent cancer worldwide, and compare them with other instruments.
A longitudinal survey in Indonesia (2023-2024) with 300 female patients used the EQ-HWB, 5-level EQ-5D (EQ-5D-5L), Functional Assessment of Cancer Therapy - General (from which Functional Assessment of Cancer Therapy Eight Dimension [FACT-8D] was derived), and Warwick-Edinburgh Mental Wellbeing Scale (WEMWBS, from which the Short WEMWBS was derived). Distributional characteristics, convergent validity, known-group validity (Student's t test or analysis of variance), test-retest reliability, and responsiveness were assessed.
All patients reported problems in at least 1 EQ-HWB item. The EQ-HWB-S index (11%) had a lower ceiling than the EQ-5D-5L (35%) and the Short WEMWBS (15.3%), but not the FACT-8D (5%). EQ-HWB-S index values correlated strongly with EQ-5D-5L (r = 0.73) and FACT-8D index values (r = 0.70), whereas EQ-HWB level sum scores correlated strongly with Functional Assessment of Cancer Therapy - General (r = 0.69) and moderately with WEMWBS (r = 0.49). The EQ-HWB and EQ-HWB-S discriminated across known groups comparably with the EQ-5D-5L and FACT-8D with large effect sizes according to EuroQol visual analog scale groups, number of symptoms, and general health and exhibited excellent instrument-level test-retest reliability (intraclass correlations, 0.79-0.83) and acceptable responsiveness (standardized response means, |0.24| to |0.97|).
This study represents one of the first validations of the EQ-HWB and EQ-HWB-S in any clinical population. Both instrument versions demonstrate robust psychometric performance. The EQ-HWB-S can be recommended to inform resource allocation decisions of breast cancer treatments.
欧洲五维健康量表(EQ-HWB)是一种新的通用测量工具,涵盖了与健康相关生活质量之外的概念,有25项的长式版本和较短的9项版本(EQ-HWB-S)。本研究旨在评估这两个版本在乳腺癌患者中的心理测量性能,乳腺癌是全球最常见的癌症,并将它们与其他工具进行比较。
在印度尼西亚进行的一项纵向调查(2023 - 2024年),对300名女性患者使用了EQ-HWB、5级欧洲五维健康量表(EQ-5D-5L)、癌症治疗功能评估通用版(从中衍生出癌症治疗功能评估八维度量表[FACT-8D])以及沃里克 - 爱丁堡心理健康量表(WEMWBS,从中衍生出简短WEMWBS)。评估了分布特征、收敛效度、已知组效度(学生t检验或方差分析)、重测信度和反应度。
所有患者至少在1项EQ-HWB项目中报告有问题。EQ-HWB-S指数(11%)的天花板效应低于EQ-5D-5L(35%)和简短WEMWBS(15.3%),但不低于FACT-8D(5%)。EQ-HWB-S指数值与EQ-5D-5L(r = 0.73)和FACT-8D指数值(r = 0.70)强烈相关,而EQ-HWB水平总分与癌症治疗功能评估通用版(r = 0.69)强烈相关,与WEMWBS中度相关(r = 0.49)。根据欧洲五维健康量表视觉模拟量表分组、症状数量、总体健康状况,EQ-HWB和EQ-HWB-S在已知组间的区分度与EQ-5D-5L和FACT-8D相当,效应量较大,并且表现出出色的工具层面重测信度(组内相关系数,0.79 - 0.83)和可接受的反应度(标准化反应均值,|0.24|至|0.97|)。
本研究是对EQ-HWB和EQ-HWB-S在任何临床人群中的首次验证之一。两个工具版本都显示出稳健的心理测量性能。EQ-HWB-S可被推荐用于为乳腺癌治疗的资源分配决策提供信息。